Carbogen Amcis Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 590

Employees

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 4

  • Investments
  • 1

Carbogen Amcis General Information

Description

Provider of drug development and commercialization services catering to the pharmaceutical and biopharmaceutical industries. The company offers active pharmaceutical ingredients and vitamin D analogs, cholesterol and lanolin derivatives products for preclinical studies, clinical trials and commercial use.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Hauptstrasse 171
  • 4416 Bubendorf
  • Switzerland
+41 058
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Parent Company
Corporate Office
  • Hauptstrasse 171
  • 4416 Bubendorf
  • Switzerland
+41 058

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carbogen Amcis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Carbogen Amcis‘s full profile, request access.

Request a free trial

Carbogen Amcis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of drug development and commercialization services catering to the pharmaceutical and biopharmaceutical industr
Other Healthcare Services
Bubendorf, Switzerland
590 As of 2022

Baudette, MN
 

Basel, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Carbogen Amcis Competitors (13)

One of Carbogen Amcis’s 13 competitors is ANI Pharmaceuticals, a Corporation company based in Baudette, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ANI Pharmaceuticals Corporation Baudette, MN
Lonza Group Corporation Basel, Switzerland
Parexel International Private Equity-Backed Durham, NC
Patheon Formerly PE-Backed Waltham, MA
Cobra Bio-Manufacturing Corporation Keele, United Kingdom
You’re viewing 5 of 13 competitors. Get the full list »

Carbogen Amcis Patents

Carbogen Amcis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220064125-A1 Novel processes Active 19-Oct-2018
US-11724988-B2 Processes Active 19-Oct-2018
GB-201304323-D0 Bortezomib Inactive 11-Mar-2013
US-9695185-B2 Synthetic methods for spiro-oxindole compounds Inactive 14-Oct-2009
US-20160326184-A1 Synthetic methods for spiro-oxindole compounds Active 14-Oct-2009 C07D491/20
To view Carbogen Amcis’s complete patent history, request access »

Carbogen Amcis Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carbogen Amcis Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Carbogen Amcis‘s full profile, request access.

Request a free trial

Carbogen Amcis Acquisitions (1)

Carbogen Amcis’s most recent deal was a Merger/Acquisition with Creapharm Parenterals. The deal was made on 16-Jan-2012.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Creapharm Parenterals 16-Jan-2012 Merger/Acquisition Biotechnology
To view Carbogen Amcis’s complete acquisitions history, request access »

Carbogen Amcis FAQs

  • When was Carbogen Amcis founded?

    Carbogen Amcis was founded in 2000.

  • Where is Carbogen Amcis headquartered?

    Carbogen Amcis is headquartered in Bubendorf, Switzerland.

  • What is the size of Carbogen Amcis?

    Carbogen Amcis has 590 total employees.

  • What industry is Carbogen Amcis in?

    Carbogen Amcis’s primary industry is Other Healthcare Services.

  • Is Carbogen Amcis a private or public company?

    Carbogen Amcis is a Private company.

  • What is Carbogen Amcis’s current revenue?

    The current revenue for Carbogen Amcis is .

  • Who are Carbogen Amcis’s investors?

    Solutia has invested in Carbogen Amcis.

  • Who are Carbogen Amcis’s competitors?

    ANI Pharmaceuticals, Lonza Group, Parexel International, Patheon, and Cobra Bio-Manufacturing are some of the 13 competitors of Carbogen Amcis.

  • When was Carbogen Amcis acquired?

    Carbogen Amcis was acquired on 15-Aug-2021.

  • Who acquired Carbogen Amcis?

    Carbogen Amcis was acquired by Dishman Carbogen Amics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »